Related Experiment Video
Updated: Sep 18, 2025

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
Published on: June 20, 2025
Multidisciplinary Approach to Familial Pulmonary Fibrosis
Katherine A Cheng1, Rose McNulty1, Holly Nichols1
1From the Department of Radiology (K.A.C., R.M., H.N., H.P.M., T.S.H.), Department of Pathology (J.C.), and Division of Pulmonary, Allergy, and Critical Care Medicine (A.S.), Duke University Medical Center, 2301 Erwin Rd, Box 3808, Durham, NC 27710; Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio (A.T., E.C.); and Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, Calif (M.V.).
None:
Familial pulmonary fibrosis (FPF) represents a subset of patients with interstitial lung disease that can be a diagnostic dilemma for the clinician and radiologist. Diagnosis can be challenging, as the age at presentation and penetrance can vary even among family members. In fact, many of these diseases have been only recently discovered with improved gene sequencing. In addition, imaging patterns are often unclassifiable, and there can be a wide range of extrapulmonary symptoms such as bone marrow and liver failure, which can further obscure the diagnosis. Given that these patients have an overall worse prognosis than that of sporadic cohorts, accurate and early diagnosis is pivotal. The authors review the general concepts of FPF and highlight the known key mutations implicated in FPF, including those that cause abnormal surfactant function, premature shortening of telomeres, and other specific genetic syndromes such as dyskeratosis congenita, Hermansky-Pudlak syndrome, and coatomer-associated protein α syndrome. The clinical presentations and imaging findings are also highlighted. The authors raise awareness of FPF among radiologists who may encounter this entity when interpreting imaging or participating in multidisciplinary conferences. ©RSNA, 2025 Supplemental material is available for this article.
More Related Videos
06:03Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Cystic Fibrosis: Management
Sinus disease and chronic...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Other Pulmonary Disorders
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...